Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Passes Below 200 Day Moving Average of $0.38

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.38 and traded as low as $0.37. Galmed Pharmaceuticals shares last traded at $0.42, with a volume of 82,589 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of Galmed Pharmaceuticals in a research report on Friday. They set a “sell” rating for the company.

Galmed Pharmaceuticals Price Performance

The company has a market cap of $2.09 million, a PE ratio of -0.13 and a beta of 0.83. The firm has a 50-day simple moving average of $0.37 and a two-hundred day simple moving average of $0.38.

Galmed Pharmaceuticals (NASDAQ:GLMD) last released its earnings results on Thursday, April 4th. The biopharmaceutical company reported ($0.98) earnings per share (EPS) for the quarter.

About Galmed Pharmaceuticals

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.